Safety, Reactogenicity and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A/H7N9 Inactivated Influenza Vaccines With or Without AS03 Adjuvant
Conditions: Avian Influenza; Influenza Immunisation Interventions: Biological: A/H7N9; Drug: AS03; Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013; Other: Phosphate Buffered Saline (PBS) diluent Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Influenza | Influenza Vaccine | Research | Vaccines